Background The Committee for the Standardization of Renal Pathological Diagnosis and the Working Group for Renal Biopsy Database of the Japanese Society of Nephrology started the first nationwide, web-based, and prospective registry system, the Japan Renal Biopsy Registry (J-RBR), to record the pathological, clinical, and laboratory data of renal biopsies in 2007. Methods The patient data including age, gender, laboratory data, and clinical and pathological diagnoses were recorded on the web page of the J-RBR, which utilizes the system of the
Introduction
There has been no national registry of renal biopsies in Japan. The Committee for the Standardization of Renal Pathological Diagnosis and the Working Group for Renal Biopsy Database in the Japanese Society of Nephrology established the first nationwide, web-based, and prospective registry system, the Japan Renal Biopsy Registry (J-RBR), to record pathological, clinical, and laboratory data regarding all renal biopsies performed in 2007.
To date, the epidemiological and clinical data of renal diseases are available from nationwide registries of renal biopsies from the United Kingdom [1] , Italy [2] , Denmark [3] , Spain [4] , the Czech Republic [5] , and Australia [6] . The role of a renal biopsy registry has been recently encouraged [7] . In Japan, several surveys were temporarily conducted for patients with restricted renal diseases, including primary glomerulonephritis [8] , idiopathic membranous nephropathy (MN) [9] , and immunoglobulin (Ig) A nephropathy (IgAN) [10] . However, there has been no web-based, nationwide, or prospective registry system of overall renal biopsies in Japan.
The aim of the current study was to provide data to investigate the epidemiology and frequency of renal diseases with a histological diagnosis for patients registered in 2007 and 2008 on the J-RBR.
for Renal Biopsy Database in the Japanese Society of Nephrology participated in this study. The report includes the data from patients on the J-RBR, registered prospectively from January to December of 2007 and 2008. Patient data including age, gender, laboratory data, and the clinical and pathological diagnoses were electronically recorded at each institution and registered on the web page of the J-RBR utilizing the system of Internet Data and Information Center for Medical Research (INDICE) in the University Hospital Medical Information Network (UMIN). The ethical committee of the Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences comprehensively approved the study, and a local committee of participating centers and their affiliated hospitals individually approved the study. Written informed consent was obtained from the patients at the time of biopsy or before participation in the study. The J-RBR is registered to the Clinical Trial Registry of UMIN (registered number UMIN000000618) and is available in Japanese and English.
Clinical or renal histopathological diagnosis and laboratory data Three classifications, clinical diagnosis, histological diagnosis by pathogenesis, and histological diagnosis by histopathology, were selected for each case (Supplementary  Table) from the J-RBR. The classification of clinical diagnoses was determined as follows: acute nephritic syndrome, rapidly progressive nephritic syndrome, recurrent or persistent hematuria, chronic nephritic syndrome, nephrotic syndrome, renal disorder with metabolic disease, renal disorder with collagen disease or vasculitis, hypertensive nephropathy, inherited renal disease, acute renal failure, drug-induced nephropathy, renal transplantation, and others. The definitions of the former five clinical diagnoses were based on the clinical syndromes and glomerular histopathology in the classification of glomerular diseases [11] . Acute nephritic syndrome was defined as a syndrome characterized by the abrupt onset of hematuria, proteinuria, hypertension, decreased glomerular filtration, and edema. Rapidly progressive nephritic syndrome was defined as an abrupt or insidious onset of hematuria, proteinuria, anemia, and rapidly progressing renal failure. Recurrent or persistent hematuria included the insidious or abrupt onset of gross or microscopic hematuria with little or no proteinuria and no evidence of other features of nephritic syndrome. Chronic nephritic syndrome was defined as slowly developing renal failure accompanied by proteinuria, hematuria, with or without hypertension. Nephrotic syndrome was defined as massive proteinuria [3.5 g/day and hypoalbuminemia of \3 g/dL of serum albumin with or without edema or hypercholesteremia.
The renal histological diagnosis is classified either according to pathogenesis (A) or by histopathology (B) as follows: (A) primary glomerular disease (except IgAN), IgAN, purpura nephritis, lupus nephritis, myeloperoxidaseantineutrophil cytoplasmic antibody (MPO-ANCA)-positive nephritis, protein 3 (PR3)-ANCA-positive nephritis, anti-glomerular basement membrane antibody nephritis, hypertensive nephrosclerosis, thrombotic microangiopathy, diabetic nephropathy, amyloid nephropathy, Alport syndrome, thin basement membrane disease, infection-related nephropathy, transplanted kidney, and others; (B) minor glomerular abnormalities, focal and segmental glomerulosclerosis (FSGS), MN, mesangial proliferative glomerulonephritis, endocapillary proliferative glomerulonephritis, membranoproliferative glomerulonephritis (MPGN) (type I, III), dense deposit disease, crescentic and necrotizing glomerulonephritis, sclerosing glomerulonephritis, nephrosclerosis, acute interstitial nephritis, chronic interstitial nephritis, acute tubular necrosis, transplanted kidney, and others. IgAN (Berger disease) was separated from primary glomerular diseases on the basis of basic glomerular alterations in the classification of glomerular diseases [11] . Clinical data, including urinalysis, daily proteinuria, serum creatinine concentrations, total protein, albumin, and total cholesterol values were also recorded, but only the frequency of the disease is described here.
Statistics
Data were expressed as mean ± SD as appropriate. Statistical analyses were performed using the JMP software program, version 8 (SAS Institute Inc., Cary, NC, USA). Fig. 1 , and reveals a different age and gender distribution in native kidneys and renal grafts.
Results

Baseline characteristics of registered biopsies
The frequency of clinical diagnoses
The clinical diagnosis and renal histological diagnosis as classified by pathogenesis and by histopathology were determined for each biopsy. A clinical diagnosis of chronic nephritic syndrome was the most frequent, followed by nephrotic syndrome and renal transplantation in 2007, which was similar in 2008 (Table 2) . In native kidneys, the majority of the cases corresponded to chronic nephritic syndrome, followed by nephrotic syndrome and recurrent or persistent hematuria or renal disorder with collagen disease or vasculitis in 2007 (Table 2 ). Similar frequencies of chronic nephritic syndrome, nephrotic syndrome and renal disorder with collagen disease or vasculitis were observed in 2008 ( Table 2 ).
The frequency of pathological diagnoses Pathological diagnoses were classified by pathogenesis (Table 3 ) and histopathology (Table 4 ). In the classification of pathogenesis, IgAN was diagnosed most frequently, followed by primary glomerular disease (except IgAN) and renal grafts both in 2007 and 2008 (Table 3 ). In the present cohort, except for renal grafts, the frequency of IgAN was 32.9%, followed by primary glomerular disease (except IgAN) (26.3%) and diabetic nephropathy (5.9%) in 2007 (Table 3) . A slightly lower frequency of IgAN was present (30.2%), but similar frequencies of primary glomerular disease (except IgAN) (26.3%) and diabetic nephropathy (5.1%) were observed in 2008 (Table 3) .
In the pathological diagnoses as classified by histopathology, mesangial proliferative glomerulonephritis was primarily observed in 2007 and 2008 (Table 4 ). In the present cohort, except for renal grafts, the frequency of mesangial proliferative glomerulonephritis was the highest followed by MN, minor glomerular abnormalities, nephrosclerosis, and crescentic and necrotizing glomerulonephritis in 2007 (Table 4 ). In 2008, mesangial proliferative glomerulonephritis was the most frequently diagnosed, with minor glomerular abnormalities being the second, and MN being the third (Table 4) .
Primary glomerular disease (except IgAN) and nephrotic syndrome
In the cohort of primary glomerular disease as classified by pathogenesis, MN was predominant, followed by mesangial proliferative glomerulonephritis, minor glomerular abnormalities, and FSGS in 2007 (Table 5 ). In 2008, MN was still the most frequently diagnosed, present at the same frequency as minor glomerular abnormalities (Table 5 ).
In nephrotic syndrome as classified by clinical diagnosis, primary glomerular disease (except IgAN) was predominant, followed by diabetic nephropathy, amyloid nephropathy, IgAN, and lupus nephritis in 2007 (Table 6) . A similar ordering of the disease frequencies was noted in 2008 (Table 6 ). Among the primary glomerular diseases (Table 7) . In 2008, the frequency of minor glomerular abnormalities was predominant, followed by MN (Table 7) .
Clinical diagnosis of MN, minor glomerular abnormalities, and FSGS Subanalyses of subjects with a clinical diagnosis of MN, minor glomerular abnormalities, and FSGS were performed since these were the most common forms of primary glomerular diseases (except IgAN) ( Tables 8, 9 , 10). Nephrotic syndrome was the most common clinical diagnosis in MN and minor glomerular abnormalities (Tables 8, 9 ), whereas chronic nephritic syndrome was the most common in FSGS (Table 10 ). In the pathogenesis of minor glomerular abnormalities (total 195 cases), primary glomerular diseases (except IgAN) comprised 65.6% (128 cases), followed by others 13.8% (27 cases), IgAN 8.2% (16 cases) and thin basement membrane disease 5.1% (10 cases). In the pathogenesis of FSGS (total 97 cases), primary glomerular diseases (except IgAN) comprised 79.4% Renal disorder with metabolic syndrome (77 cases), followed by others 11.3% (11 cases) and hypertensive nephrosclerosis 4.1% (4 cases).
Subanalysis of IgAN
The profile, classification of clinical diagnosis, and the pathological diagnosis of IgAN, the most frequent glomerulonephritis on the J-RBR, were further analyzed (Tables 11, 12 , 13). The percentage of IgAN detected in total biopsies and native kidneys was 27.5 and 31.0% in 2007 and 2008, respectively. The average age was the fourth decade in both genders. There was no difference in the proportion based on gender (Table 11 ). The majority of the clinical and pathological diagnoses were chronic (Table 12 ) and mesangial proliferative glomerulonephritis (Table 13) , respectively.
Other diseases
Rare diseases such as Alport syndrome, Fabry disease, lipoprotein glomerulopathy, and dense deposit disease (one case each) were registered in 2007, and one subject was diagnosed with POEMS syndrome in 2008.
Discussion
The J-RBR obtained data from 818 and 1582 patients with kidney disease and renal transplantation who submitted renal biopsies in 2007 and 2008, respectively. The main objectives of the registry were, based on the histopathological findings, to establish the frequency of glomerulopathies, tubulointerstitial diseases, renal vascular disorders, and renal grafts in renal biopsies in Japan. Data for all patients with histopathological evidence of renal disease at the participating centers were collected on standard forms and registered on the J-RBR program in the UMIN-IN-DICE. Chronic nephritic syndrome was the most frequent clinical diagnosis in both years of the registry. IgAN was the most frequently diagnosed disease in renal biopsies in 2007 and 2008, consistent with previous reports [8] . In patients with nephrotic syndrome, primary glomerular diseases (except IgAN) were predominant in both years.
Regarding the classification of clinical diagnosis in native kidney biopsies, more than half were diagnosed with chronic nephritic syndrome, which was usually accompanied by urinary abnormalities, as shown in Table 2 . The frequency of clinical diagnosis may reflect the prevalence of renal biopsy in Japan. Indications of renal biopsy in Japan included urinary abnormalities such as mild-tomoderate proteinuria with or without hematuria, massive proteinuria such as nephrotic syndrome, rapidly progressive glomerulonephritis, and renal allografts (a protocol or episode biopsy). Solitary hematuria may be indicated after urological examinations. In Japan, all students in primary and junior high schools routinely undergo an annual urinalysis by the dip-stick test as one of the national health programs. Therafter students in high schools and universities and employees of companies submit to a urinalysis as part of a nationwide screening program. This social system promotes the early referral to nephrologists and may thus influence the frequency of chronic nephritic syndrome according to the clinical diagnoses of the J-RBR.
In the present study, IgAN was the most frequently diagnosed by pathological findings, which is consistent with a previous report [8] . The frequency of IgAN was 32.9% in 2007 and 30.2% in 2008 in native kidneys of patients registered on the J-RBR, which was less than that in the previous nationwide survey [8] . IgAN is the most common biopsy-proven renal disease among primary glomerulopathies in Asia as described in reports from Korea [12] and China [13] . In the United States, IgAN is the most common primary glomerulopathy in young adult Caucasians and the most common cause of end-stage renal disease, while it was found to be rare in African Americans in whom FSGS remained more common [14] . In Australia, IgAN, FSGS, lupus nephritis, and vasculitis are the most common renal diseases in adults with a male predominance, excepting lupus nephritis [6] . In Europe, IgAN is the most frequent primary glomerulonephritis in several countries [2, 4, 5, 15] , while MN is the most frequent in Macedonia [16] , MPGN in Romania [17] , and non-IgA mesangial proliferative glomerulonephritis in Serbia [18] . FSGS is the most frequent renal disease in a recent report from Brazil [19] . Because there is a different policy of renal biopsy practice in each country, it may not be easy to compare the different databases across countries. Instead, the changing frequency patterns of renal disease in the same country over a certain time period are useful to treat disease and reduce chronic kidney disease burden [20] . The frequency of nephrotic syndrome was 19.0% in 2007 and 18.5% in 2008 for patients registered on the J-RBR. Primary renal diseases were present in approximately two-thirds of all patients with nephrotic syndrome. MN was the most common primary nephrotic syndrome in 2007 (44.0%) and MCNS was the most common in 2008 (44.1%). The reason for this difference may depend on the cohort of registered biopsies in both years, since the number of patients registered was not as large as other registries [2, 4, 13, 19] .
For the registry of patients with end-stage renal disease in Japan, there has been a nationwide and yearly statistical survey of chronic dialysis patients since 1968, conducted by the Japanese Society for Dialysis Therapy in Japan [21] . The combined data of the J-RBR with this dialysis registry will allow us to evaluate the long-term outcome of patients with various renal diseases in the near future. Similarly, the combined renal transplant registry data allows the evaluation of patient outcome. A sizeable frequency of renal grafts was registered on the J-RBR. Consequently, the future analysis of renal grafts, including the frequency of the protocol and episode biopsies and the precise histological diagnosis, will be necessary.
There is no overall registry of renal biopsies in Japan at the moment. It is noteworthy that the J-RBR is webbased, and a prospective registry system that can easily increase the number of participating centers and enlarge the number of patients enroled in the future. We cannot conclude that the present sample of patients on the J-RBR in 2007 and in 2008 is actually representative of the nationwide frequency of glomerular, tubulointerstitial, or renal vascular diseases or renal grafts in Japan. However, in the near future, investigation of a larger cohort or a population-based analysis of the rate of each renal disease may reveal the actual frequency of the disease and the distribution of age ranges by utilizing the J-RBR system.
